Pathophysiology of diastolic dysfunction in chronic heart failure
Vincent F M Segers1, Gilles W De Keulenaer
1University of Antwerp, Universiteitsplein 1, Campus Drie Eiken, Bldg T, 2nd Floor, 2610 Wilrijk, Belgium.
Future Cardiology
|September 12, 2013
Summary
Diastolic dysfunction is a key feature of chronic heart failure, a growing global health issue. This review explores its mechanisms across multiple biological levels, seeking a unified understanding for new heart failure therapies.
Area of Science:
- Cardiology
- Pathophysiology
- Molecular Biology
Background:
- Chronic heart failure (CHF) presents high morbidity and mortality with increasing global incidence.
- Limited therapeutic progress in the last 20 years is partly due to CHF's heterogeneity.
- A unifying pathophysiological concept for diverse CHF phenotypes is currently lacking.
Purpose of the Study:
- To examine the role and mechanisms of diastolic dysfunction in chronic heart failure.
- To provide a comprehensive overview of diastolic dysfunction across organizational levels.
- To identify potential targets for novel heart failure therapies.
Main Methods:
- Review of existing literature on diastolic dysfunction in heart failure.
- Analysis of mechanisms at systemic, organ, tissue, cellular, and molecular levels.
- Synthesis of data to unify understanding of diastolic dysfunction in CHF.
Main Results:
- Diastolic dysfunction is a near-universal feature of chronic heart failure.
- Mechanisms of diastolic dysfunction vary across different organizational levels.
- Understanding these mechanisms is crucial for developing effective CHF treatments.
Conclusions:
- Diastolic dysfunction plays a central role in the pathophysiology of chronic heart failure.
- A multi-level approach is necessary to fully comprehend diastolic dysfunction.
- Further research into diastolic dysfunction mechanisms may lead to breakthrough therapies for heart failure.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...